Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic lupus erythematosus.

A J Swaak1, J C Nossent, R J Smeenk

  • 1Department of Rheumatology, Dr. Daniel den Hoed Clinic, Rotterdam, The Netherlands.

International Journal of Clinical & Laboratory Research
|January 1, 1992
PubMed
Summary

Increased awareness and improved diagnostic methods have changed the reported incidence of systemic lupus erythematosus (SLE). However, the disease

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ipilimumab with nivolumab in molecularly selected patients with castration-resistant prostate cancer: primary analysis of the phase II INSPIRE trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Intra-prostatic recurrences after radiotherapy with focal boost: Location and dose mapping in the FLAME trial.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2024
Same author

Longitudinal Image Data for Outcome Modeling.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

Selecting a PRO-CTCAE-based subset for patient-reported symptom monitoring in prostate cancer patients: a modified Delphi procedure.

ESMO open·2023
Same author

Androgen Deprivation therapy for Oligo-recurrent Prostate cancer in addition to radioTherapy (ADOPT): study protocol for a randomised phase III trial.

BMC cancer·2022
Same author

Phase III randomised controlled trial on PSMA PET/CT guided hypofractionated salvage prostate bed radiotherapy of biochemical failure after radical prostatectomy for prostate cancer (PERYTON-trial): study protocol.

BMC cancer·2022

Area of Science:

  • Rheumatology
  • Immunology
  • Epidemiology

Background:

  • Systemic lupus erythematosus (SLE) diagnosis has been influenced by increased disease awareness.
  • Advancements in serological detection methods, including LE cell assays and antinuclear antibody tests, have improved SLE diagnosis.
  • The relationship between SLE and rheumatoid arthritis is infrequent, with discoid LE often preceding SLE.

Purpose of the Study:

  • To evaluate changes in the diagnosis, severity, and clinical features of SLE over recent decades.
  • To determine if the expression and prognosis of SLE have changed.

Main Methods:

  • Analysis of literature regarding SLE incidence, diagnosis, and clinical features.
  • Review of serological detection methods for SLE, such as LE cell assays and antinuclear antibody assays.
  • Examination of prevalence of clinical features in large SLE patient cohorts over the last three decades.

Main Results:

  • Changes in reported SLE incidence are attributed to diagnostic advancements, not increased disease occurrence.
  • No evidence suggests that less severe SLE is currently diagnosed.
  • No significant changes in the prevalence of clinical features in SLE patients have been observed over the past 30 years.

Conclusions:

  • The expression and prognosis of systemic lupus erythematosus (SLE) have remained consistent in recent decades.
  • Diagnostic improvements, not changes in disease characteristics, account for shifts in reported SLE incidence.

Related Experiment Videos